PKBO vs. IGNY, CALA, PTEIQ, SCPS, STAB, ATHX, BTTX, APVO, MOTS, and AMPE
Should you be buying Peak Bio stock or one of its competitors? The main competitors of Peak Bio include Ignyte Acquisition (IGNY), Calithera Biosciences (CALA), PolarityTE (PTEIQ), Scopus BioPharma (SCPS), Statera Biopharma (STAB), Athersys (ATHX), Better Therapeutics (BTTX), Aptevo Therapeutics (APVO), Motus GI (MOTS), and Ampio Pharmaceuticals (AMPE). These companies are all part of the "medical" sector.
Peak Bio (NASDAQ:PKBO) and Ignyte Acquisition (NASDAQ:IGNY) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, community ranking, analyst recommendations and profitability.
Peak Bio has a beta of 0.51, meaning that its share price is 49% less volatile than the S&P 500. Comparatively, Ignyte Acquisition has a beta of 0.19, meaning that its share price is 81% less volatile than the S&P 500.
Ignyte Acquisition has lower revenue, but higher earnings than Peak Bio.
In the previous week, Peak Bio's average media sentiment score of 0.00 equaled Ignyte Acquisition'saverage media sentiment score.
Peak Bio received 1 more outperform votes than Ignyte Acquisition when rated by MarketBeat users.
61.1% of Ignyte Acquisition shares are owned by institutional investors. 19.9% of Peak Bio shares are owned by company insiders. Comparatively, 19.9% of Ignyte Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Ignyte Acquisition's return on equity of 365.46% beat Peak Bio's return on equity.
Summary
Peak Bio and Ignyte Acquisition tied by winning 4 of the 8 factors compared between the two stocks.
Get Peak Bio News Delivered to You Automatically
Sign up to receive the latest news and ratings for PKBO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Peak Bio Competitors List
Related Companies and Tools
